pidotimod in treatment of acute respiratory infection in frequently ailing children

Clicks: 113
ID: 238016
2009
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #53 of 111 articles by views in Biocontrol science

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
This trial studied effectiveness and safety of pidotimoid (Imunorix) in complex treatment of children with acute respiratory infection (ARI). Treatment with pidotimoid during 2 weeks (n = 30) resulted in lesser duration of fever and intoxication symptoms, and symptoms of laryngo-tracheitis, compared to control group (n = 30). Besides, children from pidotimoid group showed more rapid transformation of dry cough to hydrated cough, and decrease of its intensity. This beneficial change was accompanied by improvement of microbiocenosis. Effectiveness of pidotimoid was estimated by 73% of doctors as «good» (67% in control group). There was no any complication, related to treatment with this medication. The rate of repeated cases of ARI was three times lower then in control group in 6 months. All patients with ARI had no recurrent laryngeal stenosis.
Key words: frequently ailing children, acute respiratory infection, treatment, prophylaxis, pidotimoid.
(Voprosy sovremennoi pediatrii — Current Pediatrics. 2009;8(2):27-33)
Reference Key
kharlamova2009voprosypidotimod Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;F.S. Kharlamova;V.F. Uchaikin;O.V. Kladova;S.L. Bevza
Journal Biocontrol science
Year 2009
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.